Aly A. Abdelbary

2.0k total citations
28 papers, 1.6k citations indexed

About

Aly A. Abdelbary is a scholar working on Pharmaceutical Science, Dermatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aly A. Abdelbary has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmaceutical Science, 5 papers in Dermatology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aly A. Abdelbary's work include Advancements in Transdermal Drug Delivery (16 papers), Advanced Drug Delivery Systems (16 papers) and Drug Solubulity and Delivery Systems (11 papers). Aly A. Abdelbary is often cited by papers focused on Advancements in Transdermal Drug Delivery (16 papers), Advanced Drug Delivery Systems (16 papers) and Drug Solubulity and Delivery Systems (11 papers). Aly A. Abdelbary collaborates with scholars based in Egypt, United States and Canada. Aly A. Abdelbary's co-authors include Abdulaziz Mohsen Al-mahallawi, Mohamed H.H. AbouGhaly, Wessam H. Abd-Elsalam, Abdelhalim I. Elassasy, Mohamed A. El-Nabarawi, Mona Hassan Aburahma, Hanan Refai, Rofida Albash, Ahmed Hassen Elshafeey and Shaimaa Mosallam and has published in prestigious journals such as International Journal of Pharmaceutics, International Journal of Nanomedicine and AAPS PharmSciTech.

In The Last Decade

Aly A. Abdelbary

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aly A. Abdelbary Egypt	20	1.1k	342	231	193	181	28	1.6k
Abdulaziz Mohsen Al-mahallawi Egypt	22	852 0.8×	386 1.1×	131 0.6×	214 1.1×	241 1.3×	45	1.6k
Heba F. Salem Egypt	28	954 0.8×	452 1.3×	174 0.8×	131 0.7×	236 1.3×	71	1.8k
Yuehong Xu China	23	793 0.7×	382 1.1×	376 1.6×	161 0.8×	200 1.1×	46	1.4k
Vamshi Krishna Rapalli India	28	1.0k 0.9×	429 1.3×	487 2.1×	250 1.3×	244 1.3×	34	2.0k
Nawal M. Khalafallah Egypt	16	1.1k 1.0×	420 1.2×	373 1.6×	123 0.6×	116 0.6×	34	1.6k
Mina Ibrahim Tadros Egypt	23	1.2k 1.1×	298 0.9×	123 0.5×	173 0.9×	272 1.5×	49	1.7k
Srividya Gorantla India	27	880 0.8×	349 1.0×	356 1.5×	260 1.3×	245 1.4×	38	1.7k
Ghada A. Abdelbary Egypt	23	1.4k 1.3×	452 1.3×	136 0.6×	264 1.4×	237 1.3×	32	1.9k
Ranendra Narayan Saha India	20	665 0.6×	382 1.1×	170 0.7×	79 0.4×	239 1.3×	36	1.4k
Mahmoud H. Teaima Egypt	23	709 0.6×	281 0.8×	133 0.6×	129 0.7×	241 1.3×	103	1.4k

Countries citing papers authored by Aly A. Abdelbary

Since Specialization

Citations

This map shows the geographic impact of Aly A. Abdelbary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly A. Abdelbary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly A. Abdelbary more than expected).

Fields of papers citing papers by Aly A. Abdelbary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aly A. Abdelbary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly A. Abdelbary. The network helps show where Aly A. Abdelbary may publish in the future.

Co-authorship network of co-authors of Aly A. Abdelbary

This figure shows the co-authorship network connecting the top 25 collaborators of Aly A. Abdelbary. A scholar is included among the top collaborators of Aly A. Abdelbary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aly A. Abdelbary. Aly A. Abdelbary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdelbary, Aly A., et al.. (2023). Brij® integrated bilosomes for improving the transdermal delivery of niflumic acid for effective treatment of osteoarthritis: In vitro characterization, ex vivo permeability assessment, and in vivo study. International Journal of Pharmaceutics. 640. 123024–123024. 28 indexed citations

Elshafeey, Ahmed Hassen, et al.. (2023). Implementing Nanovesicles for Boosting the Skin Permeation of Non-steroidal Anti-inflammatory Drugs. AAPS PharmSciTech. 24(7). 195–195. 12 indexed citations

Mosallam, Shaimaa, et al.. (2021). Fabrication of Highly Deformable Bilosomes for Enhancing the Topical Delivery of Terconazole: In Vitro Characterization, Microbiological Evaluation, and In Vivo Skin Deposition Study. AAPS PharmSciTech. 22(2). 74–74. 51 indexed citations

Al-mahallawi, Abdulaziz Mohsen, Aly A. Abdelbary, & Sally A. El‐Zahaby. (2021). Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: In vitro and in vivo evaluation. International Journal of Pharmaceutics. 600. 120490–120490. 54 indexed citations

Abdallah, Marwa H., et al.. (2021). TOPICAL DELIVERY OF QUERCETIN LOADED TRANSFERSOMES FOR WOUND TREATMENT: IN VITRO AND IN VIVO EVALUATION. International Journal of Applied Pharmaceutics. 189–197. 8 indexed citations

Mosallam, Shaimaa, et al.. (2021). Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation. International Journal of Nanomedicine. Volume 16. 119–132. 63 indexed citations

Mohamed, Magdy I., et al.. (2019). Preparation and evaluation of optimized zolmitriptan niosomal emulgel. Drug Development and Industrial Pharmacy. 45(7). 1157–1167. 24 indexed citations

Albash, Rofida, Mohamed A. El-Nabarawi, Hanan Refai, & Aly A. Abdelbary. (2019). <p>Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment</p>. International Journal of Nanomedicine. Volume 14. 6555–6574. 107 indexed citations

Albash, Rofida, Aly A. Abdelbary, Hanan Refai, & Mohamed A. El-Nabarawi. (2019). <p>Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation</p>. International Journal of Nanomedicine. Volume 14. 1953–1968. 120 indexed citations

10.

Abdelbary, Aly A., et al.. (2018). Improved Targeting and Tumor Retention of a Newly Synthesized Antineoplaston A10 Derivative by Intratumoral Administration: Molecular Docking, Technetium 99m Radiolabeling, and In Vivo Biodistribution Studies. Cancer Biotherapy and Radiopharmaceuticals. 33(6). 221–232. 6 indexed citations

11.

Abdelbary, Aly A., et al.. (2018). Design and development of microemulsion systems of a new antineoplaston A10 analog for enhanced intravenous antitumor activity: In vitro characterization, molecular docking, 125I-radiolabeling and in vivo biodistribution studies. International Journal of Pharmaceutics. 545(1-2). 240–253. 19 indexed citations

12.

Abdelbary, Aly A., et al.. (2018). Fabrication of Nanosuspension Directly Loaded Fast-Dissolving Films for Enhanced Oral Bioavailability of Olmesartan Medoxomil: In Vitro Characterization and Pharmacokinetic Evaluation in Healthy Human Volunteers. AAPS PharmSciTech. 19(5). 2118–2132. 24 indexed citations

13.

Abdelbary, Aly A., et al.. (2018). Fabrication of novel elastosomes for boosting the transdermal delivery of diacerein: statistical optimization, ex-vivo permeation, in-vivo skin deposition and pharmacokinetic assessment compared to oral formulation. Drug Delivery. 25(1). 815–826. 47 indexed citations

14.

Abdelbary, Aly A., Abdulaziz Mohsen Al-mahallawi, Mohamed E. A. Abdelrahim, & Ahmed Mahmoud Abdelhaleem Ali. (2015). Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. International Journal of Nanomedicine. 10. 6339–6339. 50 indexed citations

15.

Al-mahallawi, Abdulaziz Mohsen, Aly A. Abdelbary, & Mona Hassan Aburahma. (2015). Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. International Journal of Pharmaceutics. 485(1-2). 329–340. 195 indexed citations

16.

Elsayed, Ibrahim, et al.. (2014). Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. International Journal of Nanomedicine. 9. 2943–2943. 64 indexed citations

17.

Bendas, Ehab R. & Aly A. Abdelbary. (2014). Instantaneous enteric nano-encapsulation of omeprazole: Pharmaceutical and pharmacological evaluation. International Journal of Pharmaceutics. 468(1-2). 97–104. 32 indexed citations

18.

Abdelbary, Aly A., et al.. (2013). Design and development of novel lipid based gastroretentive delivery system: response surface analysis,in-vivoimaging and pharmacokinetic study. Drug Delivery. 22(1). 37–49. 10 indexed citations

19.

Abdelbary, Aly A., Xiaoling Li, Mohamed A. El-Nabarawi, Abdelhalim I. Elassasy, & Bhaskara Jasti. (2013). Comparison of nanomilling and coprecipitation on the enhancement ofin vitrodissolution rate of poorly water-soluble model drug aripiprazole. Pharmaceutical Development and Technology. 19(4). 491–500. 11 indexed citations

20.

Abdelbary, Aly A., et al.. (2011). Comparative In vivo Evaluation of Aripiprazole Coprecipitate, Nanoparticles and Marketed Tablets in Healthy Human Volunteers and In vitro-In vivo Correlation. Current Trends in Biotechnology and Pharmacy. 5(4). 1397–1409. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact